Centerpoint Advisory Group’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76M Buy
115,720
+2,183
+2% +$86.3K 3.02% 7
2026
Q1
$4.04M Buy
113,537
+1,462
+1% +$54.7K 3.04% 8
2025
Q4
$4.28M Buy
112,075
+6,375
+6% +$244K 3.3% 7
2025
Q3
$3.98M Buy
105,700
+7,966
+8% +$291K 3.1% 8
2025
Q2
$3.45M Buy
97,734
+2,729
+3% +$89.5K 2.99% 9
2025
Q1
$3.07M Buy
95,005
+4,520
+5% +$152K 3.02% 9
2024
Q4
$3.01M Buy
+90,485
New +$3.05M 2.91% 9

Other funds holding TCAF

Centerpoint Advisory Group's TCAF Position: Q2 2026 in Review

Centerpoint Advisory Group increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 1.9% in Q2 2026, buying an estimated $86.3K and bringing the position to 115,720 shares worth $4.76M. The position accounts for 3.02% of the portfolio, ranked #7.

Centerpoint Advisory Group first reported a position in TCAF in Q4 2024 and has held it in 7 quarters since. 357 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Centerpoint Advisory Group held 115,720 shares of T. Rowe Price Capital Appreciation Equity ETF worth $4.76M as of Q2 2026.
  • Centerpoint Advisory Group bought 2,183 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $86.3K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 3.02% of Centerpoint Advisory Group's portfolio in Q2 2026, its #7 holding.
  • Centerpoint Advisory Group first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 357 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Centerpoint Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.